ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
about
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@ast
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@en
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@nl
type
label
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@ast
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@en
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@nl
prefLabel
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@ast
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@en
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@nl
P2093
P2860
P50
P1476
ERCC1 polymorphisms as prognos ...... th platinum-based chemotherapy
@en
P2093
Barbara Frau
Bruno Massidda
Francesca Notari
MariaCristina Sini
MariaTeresa Ionta
Mario Budroni
Valeria Pusceddu
P2860
P2888
P356
10.1186/S12967-014-0272-4
P577
2014-09-25T00:00:00Z